Abstract
Transradial access (TRA) has emerged as an alternative to Transfemoral access (TFA) in percutaneous coronary intervention (PCI) of unprotected left main (ULM) lesions. Evidence is based on retrospective studies with a lack of robust clinical trials. We conducted this meta-analysis to evaluate the
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
